From my observation outside this board I would say that Oppenheimer believes M-Copax is first while the other million investors and funds are betting on T-Enox.
I'm with Dew and think that t-ENox will not get approval anytime soon (i.e at least 2 yrs) . Too much evidence has been shown that they do not have the same level of rigor in producing sameness as MNTA and as long as the FDA stands firms on its requirements (which may have been made stricter thanks to MNTA), i don't think t-enox will get approval.
On the other side of the equation (M-COpax), i dont have enough knowledge to add.